In a blog post, the MHRA is providing clarification on cross-contamination control and health-based exposure limits (HBEL). MHRA acknowledged it “provided conflicting advice during the development phase and consultation” of its HBEL Q&As.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
